Rosacea treatment with intermediate-dose isotretinoin: Follow-up with erythema and sebum measurements

Acta Dermato-Venereologica

Volumn 92, Issue 1, 2012, Pages 73-77

  Uslu, Meltem ^a   Şavk, Ekin ^a   Karaman, Göksun ^a   Şendur, Neslihan ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Dose; Erythema; Isotretinoin; Rosacea; Sebum

Indexed keywords

ISOTRETINOIN;

ADULT; AGED; ARTICLE; CHEILITIS; CLINICAL ARTICLE; DERMATITIS; DESQUAMATION; DRUG DOSE REDUCTION; DRUG EFFICACY; ERYTHEMA; FACE ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; PAPULE; PRIORITY JOURNAL; PUSTULE; ROSACEA; SEBUM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; DERMATOLOGIC AGENTS; ERYTHEMA; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; RECURRENCE; ROSACEA; SEBUM; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84855209812     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1204     Document Type: Article

References (17)

1. Baldwin HE. Systemic therapy for rosacea. Skin Ther Lett 2007; 12: 1-5, 9.
2. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Pharm Therap 1986; 25: 660-663.
3. Turjanmaa K, Reunala T. Isotretinoin treatment of rosacea. Acta Derm Venereol 1987; 67: 89-91.
4. Marsden JR, Shuster S, Neugebauer M. Response of rosacea to isotretinoin. Clin Exp Dermatol 1984; 9: 484-488.
5. Schmidt JB, Gebhart W, Raff M, Spona J. 13-cis-retinoic acid in rosacea. Acta Derm Venereol 1984; 64: 15-21.
6. Powell F. Rosacea: diagnosis and management. New York: Informa Healthcare; 2009.
7. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994; 130: 319-324.
8. Erdoǧan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-885.
9. Hofer T. Continuous "microdose" isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol 2004; 29: 196-205.
10. Gessert CE, Bamford TM. Measuring the severity of rosacea: a review. Int J Dermatol 2003; 42: 444-448.
11. Pierard GE, Pierard-Franchimont C, Marks R, Paye M, Rogiers V. EEMCO guidance for in vivo assessment of skin greasiness. Skin Pharmacol Appl Skin Physiol 2000; 13: 372-389.
12. Segot-Chicq E, Compan-Zaouati D, Wolkenstein P, Consoli S, Rodary C, Delvigne V, et al. Development and validation of a questionnaire to evaluate how a cosmetic product for oily skin is able to improve well-being in women. JEADV 2007; 21: 1181-1186.
13. Yi{dotless}lmaz E, Borchert HH. Effect of lipid containing, positively charged nanoemulsions on skin hydration, elasticity and erythema-an in vivo study. Int J Pharm 2006; 307: 232-238.
14. Korting HC, Schöllmann C. Current topical and systemic approaches to treatment of rosacea. JEADV 2009; 23: 876-882.
15. Bamford JTM, Gessert CE, Renier CM. Measurement of the severity of rosacea. J Am Acad Dermatol 2004; 51: 697-703.
16. Youn SW, Kim SJ, Hwang IA, Park KC. Evaluation of facial skin type by sebum secretion: Discrepancies between subjective descriptions and sebum secretion. Skin Res Technol 2002; 8: 168-172.
17. Fur IL, Lopez S, Morizot F, Guinot C, Tschachler E. Comparison of cheek and forehead regions by bioengineering methods in women with different self-reported "cosmetic skin types". Skin Res Technol 1999; 5: 182-188.